|
Market Closed -
Nasdaq Stockholm
20:00:00 28/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 19.92 SEK | +2.47% |
|
+0.40% | -11.86% |
| 08-28 | Synact Pharma to present new preclinical data for resomelagon at WCI | FW |
| 08-20 | SynAct Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYNACT PHARMA AB | Other Pharmaceuticals | +2.47% | +0.40% | -11.86% | +12.29% | -82.15% | 116M |  |  | |
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
